CF PharmTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	90	81.94	70.61	74.84	183.29	339.38
Short-Term Investments	5.4	6.1	5.5	5.56	-	-
Trading Asset Securities	215.85	266.06	330.85	236.39	201.44	283.05
Cash & Short-Term Investments	311.25	354.1	406.96	316.79	384.73	622.43
Cash Growth	-19.10%	-12.99%	28.46%	-17.66%	-38.19%	-
Accounts Receivable	47.69	27.13	2.87	8.94	1.09	-
Other Receivables	1.71	1.38	1.9	-	0.02	0.19
Receivables	49.4	28.51	4.77	8.94	1.6	0.74
Inventory	41.35	47.18	36.1	28.29	19.85	3.9
Restricted Cash	6.18	5.12	19.17	114.94	-	-
Other Current Assets	25.23	27.31	28.05	15.31	54.2	21.74
Total Current Assets	433.41	462.22	495.04	484.26	460.37	648.8
Property, Plant & Equipment	573.41	562.3	430.45	328.46	276.13	153.43
Long-Term Investments	1.82	1.83	1.9	-	105.76	101.84
Other Intangible Assets	30.24	33.22	44.92	52.15	32.58	9.99
Long-Term Deferred Tax Assets	96.26	94.87	92.97	83.69	62.47	-
Long-Term Deferred Charges	94.62	88.73	50.02	23.37	48.58	40.92
Other Long-Term Assets	18.22	15.81	19.85	43.27	6.92	117.31
Total Assets	1,248	1,259	1,135	1,015	992.97	1,073
Accounts Payable	21.09	20.59	27.21	13.12	13.83	7.44
Accrued Expenses	91.37	116.95	72.69	57.75	22.98	13.74
Current Portion of Long-Term Debt	10.88	18.47	0.82	-	-	-
Current Portion of Leases	1.69	2.43	1.9	1.26	-	-
Current Income Taxes Payable	2.74	4.12	2.41	5.83	0.46	0.45
Current Unearned Revenue	5.51	6.46	35.35	21.8	11.61	0.66
Other Current Liabilities	74.66	76.59	31.09	37.44	24.81	25.73
Total Current Liabilities	207.94	245.61	171.47	137.19	73.69	48.01
Long-Term Debt	63.49	55.35	19.2	-	-	-
Long-Term Leases	2.75	2.85	-	0.24	1.44	-
Long-Term Unearned Revenue	15.07	15.94	34.46	15.86	1.28	0.8
Other Long-Term Liabilities	-	-	-	-	21.8	11.8
Total Liabilities	289.24	319.74	225.12	153.29	98.21	60.61
Common Stock	370.78	370.78	370.78	370.78	370.78	370.78
Additional Paid-In Capital	-	-	-	-	1,333	1,318
Retained Earnings	-792.08	-804.9	-825.99	-857.71	-808.31	-676.59
Comprehensive Income & Other	1,380	1,373	1,365	1,349	-0.25	-0.26
Shareholders' Equity	958.74	939.28	910.02	861.93	894.76	1,012
Total Liabilities & Equity	1,248	1,259	1,135	1,015	992.97	1,073
Total Debt	78.8	79.1	21.91	1.5	1.44	-
Net Cash (Debt)	232.45	275.01	385.05	315.28	383.29	622.43
Net Cash Growth	-39.35%	-28.58%	22.13%	-17.74%	-38.42%	-
Net Cash Per Share	0.63	0.74	1.04	0.85	-	-
Filing Date Shares Outstanding	370.78	370.78	370.78	370.78	-	-
Total Common Shares Outstanding	370.78	370.78	370.78	370.78	-	-
Working Capital	225.47	216.61	323.58	347.08	386.68	600.79
Book Value Per Share	2.59	2.53	2.45	2.32	-	-
Tangible Book Value	928.5	906.06	865.11	809.78	862.17	1,002
Tangible Book Value Per Share	2.50	2.44	2.33	2.18	-	-
Buildings	236.47	236.47	167.34	154.04	106.64	47.54
Machinery	291.26	287.25	249.45	175.92	151.25	110.71
Construction In Progress	201.54	180.94	117.61	71.29	90.02	48.55
Leasehold Improvements	17.35	17.35	14.23	7.68	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.